InMed Pharmaceuticals Inc. financial data

Symbol
INM on Nasdaq
Industry
Pharmaceutical Preparations
Location
1445 885 West Georgia St., Vancouver, British Columbia, Canada
State of incorporation
British Columbia, Canada
Fiscal year end
June 30
Latest financial report
10-Q - Q4 2023 - Feb 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 594 % +77.2%
Quick Ratio 66.2 % +18.8%
Debt-to-equity 17.5 % -45.3%
Return On Equity -54.3 % +63.8%
Return On Assets -46.2 % +59.3%
Operating Margin -148 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.06M shares
Common Stock, Shares, Outstanding 5.67M shares +256%
Entity Public Float 3.18M USD -82.4%
Common Stock, Value, Issued 79.9M USD +6.78%
Weighted Average Number of Shares Outstanding, Basic 7.97M shares +247%
Weighted Average Number of Shares Outstanding, Diluted 7.97M shares +247%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.49M USD +164%
Revenue from Contract with Customer, Excluding Assessed Tax 310K USD -29.2%
Cost of Revenue 2.98M USD +235%
Research and Development Expense 3.4M USD -37.9%
General and Administrative Expense 5.48M USD -17.9%
Costs and Expenses -2.34M USD +37.1%
Operating Income (Loss) -6.97M USD +63.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.35M USD +62.5%
Income Tax Expense (Benefit) 6.8K USD
Net Income (Loss) Attributable to Parent -6.35M USD +62.5%
Earnings Per Share, Basic 0.77 USD/shares +79.1%
Earnings Per Share, Diluted 0.77 USD/shares +79.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.53M USD -16.7%
Cash, Cash Equivalents, and Short-term Investments 9.5M USD
Accounts Receivable, after Allowance for Credit Loss, Current 373K USD +357%
Inventory, Net 745K USD -53.8%
Assets, Current 11.8M USD -15.7%
Property, Plant and Equipment, Net 1.48M USD +110%
Operating Lease, Right-of-Use Asset 728K USD
Intangible Assets, Net (Excluding Goodwill) 1.86M USD -8.02%
Goodwill 2.02M USD
Other Assets, Noncurrent 100K USD -41.6%
Assets 15.3M USD -9.84%
Employee-related Liabilities, Current 102K USD
Accrued Liabilities, Current 100K USD
Liabilities, Current 1.68M USD -30%
Operating Lease, Liability, Noncurrent 803K USD +337%
Liabilities 2.48M USD -3.92%
Accumulated Other Comprehensive Income (Loss), Net of Tax 129K USD 0%
Retained Earnings (Accumulated Deficit) -105M USD -6.41%
Stockholders' Equity Attributable to Parent 12.8M USD -10.9%
Liabilities and Equity 15.3M USD -9.84%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.17M USD +3.61%
Net Cash Provided by (Used in) Financing Activities 5.43M USD -50.1%
Common Stock, Shares, Issued 5.67M shares +256%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.17M USD -60.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.53M USD -16.7%
Deferred Tax Assets, Valuation Allowance 21M USD +12.6%
Deferred Tax Assets, Gross 21M USD +12.6%
Operating Lease, Liability 1.17M USD
Depreciation 14.2K USD +76.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.5M USD -10.7%
Lessee, Operating Lease, Liability, to be Paid 1.3M USD +113%
Property, Plant and Equipment, Gross 1.65M USD +16.1%
Operating Lease, Liability, Current 364K USD -12.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 372K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 361K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.76K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 125K USD
Additional Paid in Capital 38.1M USD -0.74%
Amortization of Intangible Assets 41K USD 0%
Depreciation, Depletion and Amortization 54.8K USD +11.8%
Deferred Tax Assets, Net of Valuation Allowance 18.7M USD +33.7%
Share-based Payment Arrangement, Expense 134K USD -76%